This will help healthcare providers make better choices
Thymosin Beta-4 glaucoma models: Multiple studies showing retinal ganglion cell protection in elevated intraocular pressure models
All products are intended for research purposes only and are not for human use
Injection day and timing Choose one day per week and stick with it
For the laboratory researcher, the two peptides remain interesting tools provided they are used for what they truly are: compounds research use only With a robust but asymmetrical preclinical literature (35 AJSM 2026 studies for BPC-157, muscle/cardiac base for TB-500), and extremely limited human data on both sides, maintaining this nuance helps avoid claims not supported by science and properly position the two peptides within a well-designed research protocol
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption